Vincere Biosciences

Recent Finacing

Grant

Recent Raise

$5M

Vincere Biosciences is a Boston-area biotech developing small-molecule USP30 inhibitors to slow or halt Parkinson’s disease by improving mitochondrial quality control.

Massachusetts, United States

1-10

Private

vincerebio.com